NovaBay Pharmaceuticals, Inc.

Release Summary

NovaBay’s Auriclosene Demonstrates Statistically Significant and Clinically Meaningful Results in Phase 2b Study for the Prevention of Urinary Catheter Blockage and Encrustation

NovaBay Pharmaceuticals, Inc.